Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2011

01-06-2011 | Original Article

Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience

Authors: Thomas Opladen, Bettina Abu Seda, Anahita Rassi, Beat Thöny, Georg F. Hoffmann, Nenad Blau

Published in: Journal of Inherited Metabolic Disease | Issue 3/2011

Login to get access

Abstract

In every newborn with even mild hyperphenylalaninemia (HPA) tetrahydrobiopterin (BH4) deficiencies need to be excluded as soon as possible. Differential diagnosis is most commonly performed by analysis of urinary neopterin and biopterin. In 2005 a new method for the measurement of neopterin, biopterin and other pterins in dried blood spot (DBS) on filter paper was introduced. In order to evaluate the usefulness of this method as a standard tool for differential diagnosis of HPAs we analyzed neopterin, biopterin, pterin and dihydropteridine reductase activity in DBS from 362 patients with HPA over the period of five years. Age-dependent reference values were established for the HPA population. Sixty-four patients with BH4 deficiency (27 patients with 6-pyruvoyl-tetrahydropterin synthase deficiency, seven with GTP cyclohydrolase I deficiency, and 30 with dihydropteridine reductase) were identified. Reference values for neopterin and biopterin in DBS were calculated for each of the variants. 6-pyruvoyl-tetrahydropterin synthase and GTP cyclohydrolase I deficiency can be diagnosed by neopterin and biopterin analysis alone, while for diagnosis of dihydropteridine reductase deficiency additional determination of enzyme activity from the same DBS is essential. Regarding test sensitivity, the interpretation of neopterin and biopterin concentration per hemoglobin is more valid than the interpretation of neopterin and biopterin per liter. Percentage of biopterin, of the sum of neopterin and biopterin should always be calculated. In addition, determination of hemoglobin concentration is essential as a measure for efficient extraction of neopterin and biopterin. Although the measurement of neopterin and biopterin in urine is more sensitive due to the higher concentrations present, our data prove the usefulness of their measurement from DBS for the routine diagnosis of BH4 deficiencies.
Literature
go back to reference Arai N, Narisawa K, Hayakawa H, Tada K (1982) Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics 70:426–430PubMed Arai N, Narisawa K, Hayakawa H, Tada K (1982) Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics 70:426–430PubMed
go back to reference Blau N, Bonafé L, Blaskovics M (2005) Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N, Duran M, Blaskovics M, Gibson KM (eds) Physician' Guide to the Laboratory Diagnosis of Metabolic Disease. Springer, Heidelberg, pp 89–106 Blau N, Bonafé L, Blaskovics M (2005) Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N, Duran M, Blaskovics M, Gibson KM (eds) Physician' Guide to the Laboratory Diagnosis of Metabolic Disease. Springer, Heidelberg, pp 89–106
go back to reference Blau N, Thöny B (2008) Pterins and related enzymes. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics. Springer-Verlag, Berlin Heidelberg, pp 665–702CrossRef Blau N, Thöny B (2008) Pterins and related enzymes. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics. Springer-Verlag, Berlin Heidelberg, pp 665–702CrossRef
go back to reference Blau N, Thöny B, Cotton RGH, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 1725–1776 Blau N, Thöny B, Cotton RGH, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 1725–1776
go back to reference Dale RC, Brilot F, Fagan E, Earl J (2009) Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol 51:317–323PubMedCrossRef Dale RC, Brilot F, Fagan E, Earl J (2009) Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol 51:317–323PubMedCrossRef
go back to reference Dhondt JL (2006) Laboratory diagnosis of phenylketonuria. In: Blau N (ed) PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin. SPS, Heilbronn, pp 161–179 Dhondt JL (2006) Laboratory diagnosis of phenylketonuria. In: Blau N (ed) PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin. SPS, Heilbronn, pp 161–179
go back to reference Duffey TA, Bellamy G, Elliott S et al. (2010) A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler). Clin Chem 56:1854–1861PubMedCrossRef Duffey TA, Bellamy G, Elliott S et al. (2010) A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler). Clin Chem 56:1854–1861PubMedCrossRef
go back to reference Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187PubMedCrossRef Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187PubMedCrossRef
go back to reference Niederwieser A, Matasovic A, Kuster T, Staudenmann W, Pfleiderer W, Scheibenreiter S (1986) Catabolism of tetrahydrobiopterin in man. In: Cooper BA, Whitehead VM (eds) Chemistry and Biology of Pteridines 1986. Walter de Gruyter, Berlin, pp 305–308 Niederwieser A, Matasovic A, Kuster T, Staudenmann W, Pfleiderer W, Scheibenreiter S (1986) Catabolism of tetrahydrobiopterin in man. In: Cooper BA, Whitehead VM (eds) Chemistry and Biology of Pteridines 1986. Walter de Gruyter, Berlin, pp 305–308
go back to reference Paglia G, D'Apolito O, Gelzo M, Dello Russo A, Corso G (2010) Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith-Lemli-Opitz syndrome. Analyst 135:789–796PubMedCrossRef Paglia G, D'Apolito O, Gelzo M, Dello Russo A, Corso G (2010) Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith-Lemli-Opitz syndrome. Analyst 135:789–796PubMedCrossRef
go back to reference Ponzone A, Guardamagna O, Spada M et al. (1993) Hyperphenylalaninemia and pterin metabolism in serum and erythrocytes. Clin Chim Acta 216:63–71PubMedCrossRef Ponzone A, Guardamagna O, Spada M et al. (1993) Hyperphenylalaninemia and pterin metabolism in serum and erythrocytes. Clin Chim Acta 216:63–71PubMedCrossRef
go back to reference Zorzi G, Thöny B, Blau N (2002) Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. J Neurochem 80:362–364PubMedCrossRef Zorzi G, Thöny B, Blau N (2002) Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. J Neurochem 80:362–364PubMedCrossRef
go back to reference Zurflüh M, Giovannini M, Fiori L et al. (2005) Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab 86:96–103CrossRef Zurflüh M, Giovannini M, Fiori L et al. (2005) Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab 86:96–103CrossRef
Metadata
Title
Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience
Authors
Thomas Opladen
Bettina Abu Seda
Anahita Rassi
Beat Thöny
Georg F. Hoffmann
Nenad Blau
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9300-1

Other articles of this Issue 3/2011

Journal of Inherited Metabolic Disease 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine